Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma
Clinical trial NCT05464433 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05464433
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2025-04-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.